NEW YORK, March 11 (GeneWeb News) - Cheminformatics provider Sertanty and structural informatics company Eidogen -- both privately held firms -- said earlier this week that they have merged to become Eidogen-Sertanty.

Steven Muskal, founder and CEO of Sertanty, is CEO of the new company, and Derek Debe, founder and CEO of Eidogen, has assumed the role of CSO.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.